IPO Calendar: Biotechs Ambrx, Syndax Look To Debut
Eight companies are planning an IPO launch this week, four of them biotech companies that delayed their debuts planned for last week. The week that includes July 4 generally is not strong for new issues, as many traders and investors are on vacation. The largest initial public offering this week, in terms of proceeds it plans to raise, is Ambrx (AMBX). Ambrx is a clinical stage biotechnology company focused on discovering and optimizing protein